Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Mesoblast Ltd (MSB AU)
Watchlist
43
Analysis
Health Care
•
Australia
Mesoblast Limited provides biomedical services. The Company develops drugs for cardiovascular diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its business worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Mesoblast Ltd
•
13 Jul 2018 10:59
Raising FVE for Mesoblast After Adjusting for AUD as We Await 180 Day Survival Data in AGvHD
We are raising our fair value estimate for no-moat Mesoblast Ltd (MSB AU) to AUD 2.90 from AUD 2.60 previously, after adjusting for the recent...
Morningstar, Inc.
Follow
398 Views
Share
bullish
•
Mesoblast Ltd
•
01 Mar 2018 09:03
Mesoblast Books First-Half Profit and Moves Closer to FDA Approval in Pediatric AGvHD
No-moat Mesoblast Ltd (MSB AU) achieved a financial milestone in the first six months of fiscal 2018 by posting a maiden net profit after tax of...
Morningstar, Inc.
Follow
122 Views
Share
bullish
•
Thematic (Sector/Industry)
•
05 Jan 2018 09:35
Human Longevity
At KIS capital we try to keep ourselves at the forefront of technology and innovation, attempting to identify which industries may blossom, and...
KIS Capital Partners
513 Views
Share
bullish
•
Thematic (Sector/Industry)
•
08 Dec 2017 19:13
Aussie Healthcare Daily: 8 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...
Winnie Wong
180 Views
Share
bearish
•
Thematic (Sector/Industry)
•
05 Dec 2017 14:26
Aussie Healthcare Daily: 5 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...
Winnie Wong
146 Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.2
x